Advance Registration Deadline for AMCP 2020 Nears
The deadline for advance registration for the Academy of Managed Care Pharmacy's (AMCP) annual meeting in Houston is midnight PST [...]
ISPOR Announces Travel Grants for Conferences
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced the availability of travel grants for which members can apply [...]
Researchers Apply Proposed Graphical Framework for Longitudinal Studies
The authors of a recent article published in the Journal of Managed Care & Specialty Pharmacy incorporated a graphical framework [...]
Using RWD for Rare Diseases
OM1's Kathryn Starzyk, senior director of real-world evidence, in a recent tHEORetically Speaking blog post outlines how real-world data tools [...]
Report: FDA Program Leads to Billions in Price Increases
A program launched in 2006 by the Food and Drug Administration (FDA) helped ensure the safety and effectiveness of older [...]
Parents Shocked by Price of Children’s Hormone Drug
The parents of an 8-year-old girl were shocked when they discovered the price for a children's hormone blocker cost about [...]
Blog Post Highlights Tool for Tracking Low-Value Care Spending
A recent PhRMA blog post highlights a new web-based tool by the Research Consortium for Health Care Value Assessment that [...]
HIMSS, ISPOR Partner to Bolster Membership Value
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and Healthcare Information Management Systems Society (HIMSS) have partnered in a [...]
ICER Releases Final Report on Acute Treatments for Migraine
The Institute for Clinical and Economic Review (ICER) on Tuesday, Feb. 25, released its final report on three acute treatments [...]
AHIP: MCO’s Generated $6.5 Billion in Medicaid Savings in 2018
A new report by America's Health Insurance Plans (AHIP) suggests managed care organizations were able to save Medicaid programs roughly [...]
Veradigm Highlights Social Determinants of Health in New White Paper
Veradigm, a health information technology, analytics and intervention solutions company, in a new tHEORetically Speaking blog post highlights its new [...]
MAPS Announces ‘Major’ Expansion of Board of Directors
The Medical Affairs Professional Society (MAPS) on Monday, Feb. 24, announced the first "major" expansion of its board of directors [...]
MSLS Announces First-Ever Board Certification for MSLs
The Medical Science Liason Society (MSLS) announced the launch of a new MSL Board Certification program for MSLs and MSL [...]
ICER Announces RWE Partnership with Aetion
The Institute for Clinical and Economic Review (ICER) is partnering with Aetion to "generate decision-grade real-world evidence," the drug pricing [...]
PhRMA: HCCI Report ‘Overestimates Medicine Spending and Pricing’
The Health Care Cost Institute's (HCCI) recent report on health spending "overestimates medicine spending and pricing and mischaracterizes the true [...]
PBM Report Suggests Wider Use of Tools Can Lead to $1 Trillion in Savings
A new study by Visante, funded by the Pharmaceutical Care Management Association (PCMA), suggests greater use of PBM tools could [...]
Pearson: Program to Bolster Patient Involvement in Review Process
The Institute for Clinical and Economic Review's (ICER) new Patient Engagement Program is a big leap forward for the drug [...]
Tufts’ Cohen Highlights ICER’s Third Value Assessment Framework
Tufts Medical Center's Joshua Cohen, deputy director of the Center for the Evaluation of Value and Risk in Health, in [...]
Analysis Looks at ICER’s FDA Outreach Plan
A recent analysis by the Pink Sheet spotlights a new initiative by the Institute for Clinical and Economic Review (ICER) [...]
ICER Plans Review of Bladder Cancer Treatment
The Institute for Clinical and Economic Review (ICER) announced plans to review FKD Therapies Oy and Ferring Pharmaceuticals' Instiladrin for [...]
Population Health with Accountable Health Founder
Fred Goldstein, president and founder of Accountable Health, chimes in on population health in the latest Relentless Health Value podcast. [...]
ICER Releases Draft Report on Cystic Fibrosis Therapies
The Institute for Clinical and Economic Review (ICER) on Thursday, Feb. 20, released a draft evidence report on treatments for [...]
Article Highlights Digital Healthcare Ecosystem
HEOR researcher and scientific writer Michele Cleary in the latest Value & Outcomes Spotlight featured article offers expert perspectives on [...]
More on Surescripts Report
A recent PatientEngagementHIT report highlights a survey by Surescripts that found high drug prices caused a little more than half [...]
Survey: More than Half of Patients Avoid Taking Medicine Due to Cost
A recent survey conducted by Surescripts, in partnership with Engine Group, suggests a little more than half of U.S. patients [...]